|
TeraView’s goal is to establish a high growth products and solutions-based business, and strengthen its position as the dominant supplier of Terahertz based technology that can be applied to targeted markets.
The original development of semiconductor source and detector technology used in terahertz technology was carried out by Toshiba Research Europe Ltd in 1993-2001. Toshiba spun out this terahertz activity into TeraView Limited in April 2001 along with a consortium of UK-based venture capital investors. Toshiba retains a minority stake in TeraView, which holds all the original intellectual property, equipment, and personnel.
Since 2001, TeraView has been responsible for the rapid commercialization of terahertz technology past the proof-of-principle stage. The management and commercial teams have been built up, target markets have been identified and commercial focus on these established, applications and technology have been developed and our patent portfolio grown considerably.
The Company is currently focused upon establishing its technology in the pharmaceutical and analytical instrumentation market, with other select markets and revenue opportunities explored through partnerships with global players and government agencies active in those markets.
TeraView has a portfolio of investors who have continued to strongly supported the Company over the past several years, and bring both great breadth and depth of experience with spin-off technology companies:
- Amadeus Capital Partners
- TTPVentures
- Cambridge Gateway
- Quester
- University of Cambridge
- Trinity College, Cambridge
TeraView also has three corporate investors who enhance the global nature of the company and give it additional access to international markets:
- KLA Tencor, US
- Coherent, US
- Toshiba Research Europe
|
